Work

Combination therapy incorporating Bcl‐2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14)

Year: 2017
Type: article
Study design: Case Report
Institution: Mayo Clinic
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: closed
OpenAlex ID: W2766219207
FWCI: 4.537
Cites: 9
Cited by: 64
Related to: 10